Denali Therapeutics set to advance groundbreaking treatments for neurological diseases
Denali Therapeutics is advancing the fight against neurodegenerative diseases thanks to pioneering work in methods to carry ...
BioSpace4d
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, ...
Anti-Amyloid Drug Shows Promise In Preventing Alzheimer's
The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...
The US approved an Alzheimer’s drug. Seven patients subsequently died.
Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...
Bay Area scientist wins major award for multiple sclerosis research
Hauser frets that amid federal cutbacks, young scientists may turn away from medical research, knee-capping health care ...
Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
Pregabalin emerges as a growing threat in Punjab’s deepening drug crisis
Chandigarh: Pregabalin, a prescription drug used to treat neurological conditions, has emerged as a growing threat in ...
AOL11d
Undiscovered cause of Parkinson’s found for first time by scientists in huge breakthrough
“This knowledge unlocks future avenues for better drug design and discovery of a treatment that could slow or even stop ...
The Print2d
Widely abused neurological drug formulations worth over Rs 5 cr seized in Punjab in 2024
The Food and Drugs Administration of Punjab government last year seized drug formulations containing pregabalin worth Rs 5.97 crore from 72 premises, Union Health Minister J P Nadda told the Lok Sabha ...